tradingkey.logo

Baxter International Inc reports results for the quarter ended March 31 - Earnings Summary

ReutersMay 1, 2025 1:32 PM
  • Baxter International Inc BAX.N reported quarterly adjusted earnings of 55 cents​​ per share for the quarter ended March 31, lower than the same quarter last year, when the company reported EPS of 65 cents. The mean expectation of fourteen analysts for the quarter was for earnings of 48 cents per share. Wall Street expected results to range from 48 cents to 49 cents per share.

  • Revenue fell 26.9% to $2.63 billion from a year ago; analysts expected $2.59 billion.

  • Baxter International Inc's reported EPS for the quarter was 25 cents​.

  • The company reported quarterly net income of $126 million.

  • Baxter International Inc shares had fallen by 8.9% this quarter and gained 6.9% so far this year.

FORECAST CHANGES

  • The mean earnings estimate of analysts had fallen by about 5.5% in the last three months.​

  • In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

  • The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 11 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "hold"

  • Wall Street's median 12-month price target for Baxter International Inc is $38.00

This summary was machine generated from LSEG data May 1 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

QUARTER ENDING

ESTIMATE

ACTUAL

BEAT, MET, MISSED

Mar. 31 2025

0.48

0.55

Beat

Dec. 31 2024

0.52

0.58

Beat

Sep. 30 2024

0.78

0.80

Beat

Jun. 30 2024

0.66

0.68

Beat

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles